Keros Therapeutics CFO Keith Regnante Resigns, Effective Aug. 3; VP Finance Annita Tanini Named Interim Principal Financial Officer
https://www.sec.gov/ix?doc=/Archives/edgar/data/1664710/000166471026000038/kros-20260717.htm
Share
Why It Matters
The money manager at Keros Therapeutics is leaving, and someone else is taking over their job. When a key money person leaves suddenly, it's worth watching to see if the company stays on track or if anything changes about how it's doing.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.